SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Astec Lifesciences informs about press release

05 Jul 2019 Evaluate

In continuation of its letter dated 1st July, 2019 and pursuant to Regulations 47 and 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 with regard to Notice of 25th Annual General Meeting (AGM) and Notice of Book Closure, Astec Lifesciences has informed that it has enclosed copies of newspaper advertisements published on Thursday, 4th July, 2019 in Business Standard (in English language) and Mumbai Lakshadeep (in Marathi language) confirming completion of dispatch of Notice of AGM and Book Closure along with Annual Report for the Financial Year 2018-19 to the Shareholders.

The above information is a part of company’s filings submitted to BSE.


 



Astec Lifesciences Share Price

726.50 -22.90 (-3.06%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 665.00
PI Industries 3144.45
Bayer CropScience 4900.45
Sharda Cropchem 1109.70
Sumitomo Chemical 441.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×